Express Pharma - Page 401 of 2181 - Express Pharma

Lupin receives US FDA approval for Dapagliflozin tablets

Inventia enters the U.S. market with FDA approved Dapagliflozin tablets

Biocon launches Bosaya and Aukelso in the United States

Zydus launches Topiramate extended-release capsules

Alembic Pharma receives USFDA’s final approval for Fesoterodine Fumarate extended-release tablets

USFDA accepts AstraZeneca’s BLA for nirsevimab to prevent RSV lower respiratory tract disease

WuXi Biologics and GSK enter into licence agreement on multiple T Cell Engagers

PMBI launches Jan Aushadhi Chyawanprash Special

German expats in China receive first foreign COVID vaccines

US new drug price exceeds $200,000 median in 2022

Budget 2023: What industries look forward to

Lupin launches novel fixed-dose triple drug combination Difizma DPI to treat inadequately controlled asthma

USFDA allows abortion pills to be sold at retail pharmacies